Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

International Immunopharmacology

ISSN:
1567-5769
1
h-index
2
Citations
7
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
0134501220192022202320252019: Publications 1, Citations 02022: Publications 4, Citations 22023: Publications 1, Citations 02025: Publications 1, Citations 0

Citation history

01220192022202320252019: Citations 02022: Citations 22023: Citations 02025: Citations 0

Publication history

0134520192022202320252019: Publications 12022: Publications 42023: Publications 12025: Publications 1

h-index evolution

Cumulative h-index by year

0120192022202320252019: h-index 02022: h-index 12023: h-index 12025: h-index 1

Most-cited works

  1. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update20222 citations
  2. α-Ecdysone suppresses inflammatory responses via the Nrf2 pathway in lipopolysaccharide-stimulated RAW 264.7 cells20190 citations
  3. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism20220 citations
  4. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells20220 citations
  5. PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis20220 citations
  6. The interactions of docetaxel with tumor microenvironment20230 citations
  7. Application of niosomes in cancer nanotheranostics: recent progress and prospects20250 citations